Collectively, these data demonstrate highly potent MM cytotoxicity in both RAS-MT (H929 and MM1S) and RAS-WT (U266) MM-cells when Erk1/2i is combined with CDK4/6i. The gene discussed is MAPK3; the disease is Miyoshi myopathy.